483
Genzyme CorporationGenzyme Corporation – FDA 483, Feb 14, 2025
Record Details
An FDA inspection of Genzyme Corporation's Northborough, MA facility revealed three observations related to labeling, packaging, and quality control. The firm failed to follow procedures for correct drug product labeling, resulting in incorrect potency values printed on Altuviiio finished product. Additionally, examination of packaging materials was not adequately performed, and investigations into unexplained discrepancies were not consistently documented.
View Company Profile
ID · 3adce78e-cce8-40f0-a243-541478a76c60
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.